17-41586461-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000526.5(KRT14):c.374G>A(p.Arg125His) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R125G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT14 | NM_000526.5 | c.374G>A | p.Arg125His | missense_variant | 1/8 | ENST00000167586.7 | NP_000517.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT14 | ENST00000167586.7 | c.374G>A | p.Arg125His | missense_variant | 1/8 | 1 | NM_000526.5 | ENSP00000167586.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461890Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727244
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 09, 2022 | Located in the highly conserved helix initiation motif of the alpha-helical rod domain, which is intolerant to change; variants in this motif interfere with proper keratin intermediate filament assembly and function, resulting in skin fragility and/or hyperkeratosis (Chamcheu et al., 2011); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27882080, 29242947, 29410318, 29784039, 29687370, 1717157, 26432462, 28561874, 28830826, 26707537, 32484238, 33274474, 21176769, 31001817, 16098032, 19854623, 7561171) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 125 of the KRT14 protein (p.Arg125His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant epidermolysis bullosa simplex (PMID: 1717157, 16098032). ClinVar contains an entry for this variant (Variation ID: 14613). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KRT14 protein function. Experimental studies have shown that this missense change affects KRT14 function (PMID: 1717157). This variant disrupts the p.Arg125 amino acid residue in KRT14. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1717157, 16098032). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Epidermolysis bullosa simplex 1A, generalized severe Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2000 | - - |
Dermatopathia pigmentosa reticularis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Mar 07, 2022 | ACMG classification criteria: PS4 strong, PM1, PM2 moderated, PM6 moderated, PP3 supporting - |
KRT14-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 05, 2024 | The KRT14 c.374G>A variant is predicted to result in the amino acid substitution p.Arg125His. This variant has been previously reported in the heterozygous state in many individuals with epidermolysis bullosa (see for example Coulombe et al. 1991. PubMed ID: 1717157; Pfendner et al. 2005. PubMed ID: 16098032; Vahidnezhad et al. 2017. PubMed ID: 28830826, Supplementary Table S1; Mariath et al. 2019. PubMed ID: 31001817; Chen et al. 2020. PubMed ID: 32484238). The p125 residue represents a mutation hotspot with alternate amino acids changes (p.Arg125Ser, p.Arg125Gly, p.Arg125Cys, p.Arg125Pro, and p.Arg125Leu) frequently found in individuals with epidermolysis bullosa (https://www.hgmd.cf.ac.uk/ac/index.php). The p.Arg125His variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at